Drug intelligence / Profile preview

Lactolac

Development stage: Unknown
Lead developer: Paedpharm
Modality: Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics

Overview

Lactolac is a brand of probiotic dietary supplements developed and marketed by Care Pharmaceuticals, an Australian consumer healthcare company. The product line includes formulations specifically designed for digestive health and vaginal microbiota support. As a microbial therapy, Lactolac contains live probiotic strains intended to restore or maintain a healthy balance of microflora in the gastrointestinal or vaginal tracts. Depending on the specific product formulation, it is administered either orally for digestive support or vaginally for women's health applications. It is positioned as an over-the-counter (OTC) consumer healthcare product rather than a prescription pharmaceutical.

Brand names: Lactolac

Beyond the preview

Go deeper on Lactolac.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lactolac.

Explore the full profile